IMDX
Insight Molecular Diagnostics Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.13
+0.24%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 77.16x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -6.35x
- Price / sales
- 80.93x
- Price / cash flow
- -5.01x
Enterprise value
- Enterprise value
- $120.0M
- EV / sales
- 71.87x
- EV / EBITDA
- -2.56x
- EV / EBIT
- -2.81x
- Market cap
- $135.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026